Skip to main content
All lobbying filings

Medtronic, Inc.

Medtronic, Inc. filed a Q2 report for Medtronic Inc. on July 21, 2025.

Lobbying for Medtronic Inc.

As filed: MEDTRONIC, INC. for MEDTRONIC INC.

All filings by Medtronic, Inc. · Everything Medtronic Inc. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Expenses
$650,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 9

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 12
Trade (domestic/foreign)

Issues related to global supply chains including critical minerals Issues related to tariffs

Health Issues

Issues related to medical device electronic labeling, including H.R. 1539 - Medical Device Electronic Labeling Act Issues related to hypertension Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices, including within the Department of Defense supply chain Issues related to FDA device shortage reporting Issues related to artificial intelligence and other advanced software in health care Issues related to FDA workforce and product review processes Issues related to H.R. 1, the One Big Beautiful Bill Act Issues related to Parkinsons disease

Telecommunications

Issues related to cybersecurity of medical devices including reauthorization of the Cybersecurity Information Sharing Act of 2015

Labor Issues/Antitrust/Workplace

Issues related to anti-trust and competition

Copyright/Patent/Trademark

Issues related to intellectual property including S. 1553, the PREVAIL Act

Environment/Superfund

Monitoring Environmental, Social and Governance (ESG) issues Issues related to the sterilization of medical devices Issues related to the use of polyfluoroalkyl substances

Consumer Issues/Safety/Products

Issues related to data privacy and data security Issues related to artificial intelligence enabled medical devices and emerging technologies, Issues related to right to repair

Veterans

Issues related to hypertension Issues related to pain care Issues related to AI in veterans healthcare Issues related to procurement of healthcare technologies

Defense

Issues related to TRICARE health benefits management Issues related to servicing and repair of medical devices in the Department of Defense supply chain

Budget/Appropriations

Issues related to hypertension, including FY26 MilCon/Veterans Appropriations

Medicare/Medicaid

Issues related to Medicare coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717) Issues related to Medicare coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399) Issues related to Medicare Physician Fee Schedule Issues related to H.R. 1, the One Big Beautiful Bill Act Issues related to prior authorization Issues related to DME competitive bidding

Taxation/Internal Revenue Code

Issues related to the taxation of multinational corporations corporations and third party litigation funding, including provisions of H.R. 1, the One Big Beautiful Bill Act

 Bills named in this filing 5
  • H.R. 1539
    Medical Device Electronic Labeling Act
  • H.R. 1
    One Big Beautiful Bill Act
  • S. 1553
    PREVAIL Act
  • S. 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • S. 1399
    Health Tech Investment Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem